FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

256579008: Hydroxyapatite (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
382230011 Calcium hydroxyapatite en Synonym Active Entire term case insensitive SNOMED CT core module
4042144010 Durapatite en Synonym Active Entire term case insensitive SNOMED CT core module
4042145011 Durapatite (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4042146012 Hydroxyapatite en Synonym Active Entire term case insensitive SNOMED CT core module
2309181000001117 Hydroxyapatite (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxyapatite Is a Calcium compound true Inferred relationship Existential restriction modifier
Hydroxyapatite Is a Synthetic surgical material false Inferred relationship Existential restriction modifier
Hydroxyapatite Is a Hydroxyapatite false Inferred relationship Existential restriction modifier
Hydroxyapatite Is a Stone constituent false Inferred relationship Existential restriction modifier
Hydroxyapatite Is modification of Hydroxyapatite false Inferred relationship Existential restriction modifier
Hydroxyapatite Is a Phosphate salt false Inferred relationship Existential restriction modifier
Hydroxyapatite Is a Phosphate true Inferred relationship Existential restriction modifier
Hydroxyapatite Is a Surgical material true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing durapatite (medicinal product) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing calcium hydroxyapatite Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier 1
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 0.3mL prefilled syringe Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Calcium hydroxyapatite microsphere suspension in aqueous based carrier 1.3mL prefilled syringe Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Calcium hydroxyapatite crystal Is modification of False Hydroxyapatite Inferred relationship Existential restriction modifier
Hydroxyapatite Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing durapatite in parenteral dose form (medicinal product form) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing only durapatite in parenteral dose form (medicinal product form) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing carmellose and durapatite (medicinal product) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 2
Product containing only carmellose and durapatite (medicinal product) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 2
Product containing carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 2
Product containing only carmellose and durapatite in parenteral dose form (medicinal product form) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 2
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has basis of strength substance True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has precise active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing durapatite (medicinal product) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing durapatite in oral dose form (medicinal product form) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing only durapatite in oral dose form (medicinal product form) Has active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier 1
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Hydroxyapatite 3.32g granules sachets sugar free 28 sachet Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 800 tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 800 tablets (Sanofi-Synthelabo Ltd) 50 tablet 5 x 10 tablets Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) 28 sachet Has specific active ingredient True Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 800 tablets (Sanofi-Synthelabo Ltd) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Hydroxyapatite 830mg tablets 50 tablet Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Hydroxyapatite 3.32g granules sachets sugar free 28 sachet Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 800 tablets (Sanofi-Synthelabo Ltd) 50 tablet 5 x 10 tablets Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Ossopan 3.32g granules sachets (Sanofi-Synthelabo Ltd) 28 sachet Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) Has active ingredient False Hydroxyapatite Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start